Home / Denmark / NTG Nordic Transport Group A/S
NTG Nordic Transport Group A/S
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
16 disclosures on record
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| May 18, 2026 | Qube Research & Technologies Ltd | 0.00% | May 18, 2026 |
| April 27, 2026 | Qube Research & Technologies Ltd | 0.59% | April 27, 2026 |
| April 16, 2026 | Qube Research & Technologies Ltd | 0.69% | April 16, 2026 |
| April 10, 2026 | Qube Research & Technologies Ltd | 0.70% | April 10, 2026 |
| April 1, 2026 | Qube Research & Technologies Ltd | 0.61% | April 1, 2026 |
| March 31, 2026 | Qube Research & Technologies Ltd | 0.59% | March 31, 2026 |
| March 30, 2026 | Qube Research & Technologies Ltd | 0.60% | March 30, 2026 |
| March 5, 2026 | Qube Research & Technologies Ltd | 0.54% | March 5, 2026 |
| March 3, 2026 | Qube Research & Technologies Ltd | 0.61% | March 3, 2026 |
| January 29, 2026 | Qube Research & Technologies Ltd | 0.50% | January 29, 2026 |
| January 28, 2026 | Qube Research & Technologies Ltd | 0.49% | January 28, 2026 |
| January 27, 2026 | Qube Research & Technologies Ltd | 0.50% | January 27, 2026 |
| December 8, 2025 | Citadel Advisors LLC | 0.49% | December 8, 2025 |
| November 26, 2025 | Citadel Advisors LLC | 0.50% | November 26, 2025 |
| November 21, 2025 | Citadel Advisors LLC | 0.49% | November 21, 2025 |
| November 19, 2025 | Citadel Advisors LLC | 0.50% | November 19, 2025 |
Other companies sold short in Denmark
- Zealand Pharma A/S 6.75% of the capital sold short
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short